Paudie O'Connor, SVP of Global Supply Chain at Boston Scientific, discusses the company's efforts in managing supply chain volatility and sustainability. Topics include transitioning from air to ocean freight to reduce carbon footprint by 96%, building sterilization facilities closer to manufacturing sites, and innovations in packaging. O'Connor emphasizes the importance of supplier partnerships in achieving ambitious targets and redefining supply chain norms.

Jim Marucci, neurovascular president of Stryker, discusses the company's advancements in neurovascular technology, including the recent acquisition of Cerus Endovascular. They explore the development of the Target Tetra detachable coil and the potential of AI/AR in neurovascular procedures. The conversation highlights Stryker's commitment to enhancing stroke care and improving access to neurovascular treatments globally.

Kirsten Carroll, CEO of Kandu Health, discusses the importance of collaboration, defining user needs, design verification, and design validation in medtech product development. She emphasizes the significance of generating clinical evidence and effective communication for successful device launch.

Fred Khosravi, CEO of Imperative Care, discusses their approach to improving stroke care. Delphine Zurkiya from McKinsey explains how medical device companies can enhance efficiencies in R&D and customer outreach.

Welcome to DeviceTalks AI, a DeviceTalks podcast offering a comprehensive look into the intersection of AI and the medical device industry from two unique perspectives. In the first segment, Paul Friedman, MD, Chair of the Department of Cardiovascular Medicine at Mayo Clinic, and Dave McMullin, Chief Business Officer of Anumana, discuss the groundbreaking collaboration between Mayo Clinic and Anumana in applying AI to enhance cardiovascular diagnostics, particularly through ECGs. They explore how AI can detect cardiac conditions early, with a focus on the EAGLE study's findings on AI-enhanced ECGs, and discuss Anumana's role in transforming these AI innovations into accessible medical devices. In the second segment, Jeff Elton, PhD, CEO of ConcertAI, speaks to the transformative role of AI in clinical trials. He sheds light on AI's capabilities in improving patient selection for clinical trials and streamlining processes within life sciences. Dr. Elton emphasizes the broader implications of AI, from enhancing patient care to accelerating the development of new treatments, and discusses the ethical considerations of AI integration in healthcare.These interviews provide insights into the evolving roles of AI in various sectors like medtech, pharma, and biotech, showcasing its potential in transforming healthcare and research methodologies. But that's not all! Join us for the next episode of DeviceTalks AI, which features an interview with the Global Business Leader for Health and Life Sciences at Microsoft. Catch the full episode on all major podcast platforms and the DeviceTalks YouTube to dive deeper into the exciting convergence of AI and medtech. Thank you to our contributors, some of who include Catalyze Healthcare and SmartTRAK Business Intelligence, for providing vital support. To learn more about our contributors, visit: www.catalyzehealthcare.com and www.smarttrak.com. Thank you for listening to DeviceTalks AI.

Rocco De Bernardis, Global President of OTTAVA, discusses J&J MedTech's surgical robotics system, Ottava, and its future in clinical trials. Karthik Bolisetty, senior associate at VC firm Gilde Healthcare, explores the impact of GLP-1 drugs on medical device start-ups. The CEO of Aptyx, Gregg Tobin, talks about their rebranding and the importance of a brand promise. The podcast also touches on manufacturing expertise, advancements in the TAVA surgical system, and upcoming episodes in the DeviceTalks network.

In this episode of Boston Scientific Talks, Boston Scientific's electrophysiology leaders, Ken Stein, MD, SVP, Global Chief Medical Officer and Nick Spadea-Anello, Global President of Electrophysiology, offer a deep dive into the transformative potential of the FARAPULSE Pulsed Field Ablation System. They discuss the strategic development and clinical advantages of this innovative technology, emphasizing its ability to target cardiac tissue while minimizing the risk of collateral damage to vital structures like the esophagus. The duo also explores the synergistic potential of combining PFA with devices like the WATCHMAN for stroke prevention, painting a picture of a more streamlined, patient-centric approach to cardiac care. With a keen eye on the future, they discuss the vision for expanding PFA's applications, including its role in treating a broader spectrum of arrhythmias and its adaptability to various procedural settings. Tune in to learn more about Boston Scientific's forward-thinking approach to cardiac ablation. Thank you to Dassault Systèmes for sponsoring this episode. To learn how Dassault Systèmes enables innovation in medtech, visit www.medtecheco.com/lifecycle. Thank you for listening to the Boston Scientific Podcast. Subscribe to this podcast on every major podcast platform.

In this special episode of IntuitiveTalks, recorded live from DeviceTalks West, Dave Rosa, President of Intuitive, shares the experience of the company's pioneering role in surgical robotics. Rosa reflects on the initial skepticism faced by the company and the subsequent validation of their work as the industry has grown to embrace robotic assistance in surgery. He also discusses the balance between innovation and the practicalities of scaling a business, emphasizing the importance of reliability and supply chain management in healthcare technology. Rosa also addresses the future of surgical robotics, hinting at a shift towards more compact and specialized devices that could transform patient care. He highlights the economic benefits of robotic surgery, particularly its potential to reduce the overall costs of healthcare while improving surgical outcomes. A must for all medtech stakeholders, this episode offers a thoughtful perspective on leading a company at the forefront of medical technology. Rosa's conversation is a blend of personal experience and professional insights, providing valuable lessons on growth, adaptation, and the continuous effort to improve surgical care. Thanks to maxon Group for sponsoring this episode. Visit https://www.maxongroup.us/maxon/view/content/medical to learn more about how maxon Group works with medical device companies. Thank you for listening to the IntuitiveTalks Podcast. Subscribe to this podcast on every major podcast platform.

In this special episode of AbbottTalks, recorded live from DeviceTalks West, Julie Tyler, president of Abbott's Vascular business, discusses the company's strategic evolution and commitment to comprehensive patient care, including a new technology, the Esprit BTK, intended to be released next year. Additionally, Tyler provides an insider's perspective on Abbott's integration of Cardiovascular Systems Inc., revealing how this move enhances Abbott's portfolio and positions the company at the forefront of vascular health. Tyler's vision extends beyond current interventions, aiming to leverage data and predictive modeling to improve patient outcomes and potentially reduce the need for later-stage interventions. With a patient-centric approach, Tyler also discusses the challenges and successes in diversifying clinical trial demographics and expanding global reach. This episode is a must-listen for those interested in how strategic acquisitions and a holistic health model can redefine patient care. Thank you to Resonetics for sponsoring this episode. To learn more about how Resonetics works with medical device companies, visit https://resonetics.com/. Thank you for listening to the AbbottTalks Podcast. Subscribe to this podcast on every major podcast platform.

In this week’s episode, Qiagen CEO Thierry Bernard gives us a look inside the diagnostics leader both today and a few years ago when it was responded to the world’s dire need for diagnostics. Bernard takes us back to the early days of the pandemic, including his perspective on how different countries responded to the crisis. We’ll also hear his vision for the future of diagnostics including how Qiagen will make testing even simpler. At the start of the show, Host Tom Salemi and Chris Newmarker, executive editor of life sciences, talk with Senior Editor Danielle Kirsh about the recently released Women in Medtech issue of Medical Design and Outsourcing magazine. Kirsh shares data she’s collected on how many women hold senior positions in the medical device industry. We’re seeing some progress, but not enough. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network on any major podcast player.